PAX5 interacts with RIP2 to promote NF-κB activation and drug-resistance in B-lymphoproliferative disorders.
Wang D, Chen J, Li R, Wu G, Sun Z, Wang Z, Zhai Z, Fang F, Guo Y, Zhong Y, Jiang M, Xu H, Chen M, Shen G, Sun J, Yan B, Yu C, Tian Z, Xiao W.
Wang D, et al. Among authors: chen j, chen m.
J Cell Sci. 2016 Jun 1;129(11):2261-72. doi: 10.1242/jcs.183889. Epub 2016 Apr 27.
J Cell Sci. 2016.
PMID: 27122187